P

Inventor

SPARKS RICHARD B

US66 patents
⚠️ This page may combine multiple inventors who share the name “SPARKS RICHARD B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

INCYTE CORP

42 patents
US8741895B2Jun 3, 2014

Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as Janus kinase inhibitors

INCYTE CORP84 citations99
US8053433B2Nov 8, 2011

Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors

INCYTE CORP107 citations99
US7335667B2Feb 26, 2008

Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-4-yl-amines as Janus kinase inhibitors

INCYTE CORP149 citations99
US9624241B2Apr 18, 2017

Tricyclic heterocycles as BET protein inhibitors

INCYTE CORP27 citations98
US9227985B2Jan 5, 2016

Tricyclic heterocycles as bet protein inhibitors

INCYTE CORP40 citations98
US9090611B2Jul 28, 2015

Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors

INCYTE CORP60 citations98
US8993605B2Mar 31, 2015

1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase

INCYTE CORP34 citations98
US8835423B2Sep 16, 2014

Azepine inhibitors of janus kinases

INCYTE CORP71 citations97
US8822511B2Sep 2, 2014

1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase

INCYTE CORP24 citations96
US10618910B2Apr 14, 2020

Tricyclic heterocycles as BET protein inhibitors

INCYTE CORP12 citations94
US10464947B2Nov 5, 2019

Tricyclic heterocycles as BET protein inhibitors

INCYTE CORP17 citations94
US10227359B2Mar 12, 2019

Tricyclic heterocycles as bet protein inhibitors

INCYTE CORP20 citations94
US10138248B2Nov 27, 2018

Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines, substituted imidazo[1,2-b]pyridazines and substituted imidazo[1,2-a]pyrazines as PI3K-γ inhibitors

INCYTE CORP36 citations94
US10092570B2Oct 9, 2018

Heterocyclylamines as PI3K inhibitors

INCYTE CORP17 citations94
US9938294B2Apr 10, 2018

Tricyclic heterocycles as BET protein inhibitors

INCYTE CORP24 citations94
US9834565B2Dec 5, 2017

Tricyclic heterocycles as bet protein inhibitors

INCYTE CORP23 citations94
US9730939B2Aug 15, 2017

Heterocyclylamines as PI3K inhibitors

INCYTE CORP23 citations94
US9527864B2Dec 27, 2016

Tricyclic heterocycles as BET protein inhibitors

INCYTE CORP31 citations94
US9527848B2Dec 27, 2016

N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors

INCYTE CORP25 citations94
US9309251B2Apr 12, 2016

Bicyclic azaheterocyclobenzylamines as PI3K inhibitors

INCYTE CORP25 citations94
US9290514B2Mar 22, 2016

Tricyclic heterocycles as BET protein inhibitors

INCYTE CORP33 citations94
US10646492B2May 12, 2020

Heterocyclylamines as PI3K inhibitors

INCYTE CORP9 citations93
US10376513B2Aug 13, 2019

Heterocyclylamines as PI3K inhibitors

INCYTE CORP12 citations93
US10034864B2Jul 31, 2018

1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase

INCYTE CORP8 citations93
US9944646B2Apr 17, 2018

Bicyclic azaheterocyclobenzylamines as PI3K inhibitors

INCYTE CORP16 citations93
US9815839B2Nov 14, 2017

N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors

INCYTE CORP20 citations93
US9789094B2Oct 17, 2017

1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase

INCYTE CORP11 citations93
US9580419B2Feb 28, 2017

Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as Janus kinase inhibitors

INCYTE CORP10 citations93
US9320732B2Apr 26, 2016

1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase

INCYTE CORP14 citations93
US8951536B2Feb 10, 2015

N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase

INCYTE CORP25 citations92
US8377976B2Feb 19, 2013

N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase

INCYTE CORP24 citations89
US7141596B2Nov 28, 2006

Inhibitors of proteins that bind phosphorylated molecules

INCYTE CORP24 citations89
US10919912B2Feb 16, 2021

Tricyclic heterocycles as BET protein inhibitors

INCYTE CORP10 citations86
US11498926B2Nov 15, 2022

Tricyclic heterocycles as BET protein inhibitors

INCYTE CORP4 citations84
US11433071B2Sep 6, 2022

Heterocyclylamines as PI3K inhibitors

INCYTE CORP3 citations84
US10975088B2Apr 13, 2021

Imidazo[2,1-f][1,2,4]triazine compounds as pi3k-y inhibitors

INCYTE CORP6 citations84
US10738057B2Aug 11, 2020

Tertiary alcohols as PI3K-γ inhibitors

INCYTE CORP5 citations84
US10653677B2May 19, 2020

1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase

INCYTE CORP4 citations84
US10479795B2Nov 19, 2019

Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines and substituted imidazo[1,2-b]pyridazines as PI3K-gamma inhibitors

INCYTE CORP13 citations84
US10472368B2Nov 12, 2019

Heterocyclic compounds as PI3K-γ inhibitors

INCYTE CORP12 citations84
US10369137B2Aug 6, 2019

1,2,5-Oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase

INCYTE CORP5 citations84
US10259818B2Apr 16, 2019

Bicyclic azaheterocyclobenzylamines as PI3K inhibitors

INCYTE CORP12 citations84

COMBS ANDREW P

5 patents

RODGERS JAMES D

1 patent

LI YUN-LONG

1 patent

ARVANITIS ARGYRIOS G

1 patent

Showing the top 50 of 66 patents by PatentIndex Score.